newsfilter
← Latest News
Earnings Call Transcripts·

Proteon Therapeutics' (PRTO) Management Discuses Changes to the Ongoing Phase 3 PATENCY-2 Clinical Trial Conference (Transcript)

Proteon Therapeutics' (PRTO) Management Discuses Changes to the Ongoing Phase 3 PATENCY-2 Clinical Trial Conference (Transcript)